- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01437033
Breath Test for Chemicals (Volatile Organic Compounds)
A Pilot Study of a Breath Test for Assessment of Volatile Organic Compounds
Background:
- Some types of cancer, like cancer of the esophagus, are difficult to detect at an early stage. A possible detection method involves collecting breath samples to look for chemicals that may be signs of cancer. However, more research is needed to determine how different chemicals appear in different breath samples. This study will involve healthy volunteers.
Objectives:
- To study chemicals appearing in breath samples of healthy volunteers.
Eligibility:
- Healthy volunteers between 30 and 60 years of age.
Design:
- Participants will fast overnight (midnight to morning) and then provide two breath samples taken 5 minutes apart.
- Breath samples will be collected on days 1, 49, and 98 of the study
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Background:
Although breath tests are common for specific uses where the biomarker is highly concentrated (e .g. alcohol, urea for Helicobacter prylori infection), lower concentration compounds in the breath can also provide information on exogenous exposures and endogenous metabolic processes.
Employing standardized collection techniques and high sensitivity measurement technologies have shown that breath profiles can accurately identify people with diseases such as breast cancer and lung cancer.
Breath profiling technologies have great potential as non-invasive tools for diagnosis and risk stratification of precancerous disease as well as elucidation of the causes of cancer.
Prior to using breath profiles for these purposes it is essential to assess how much of the breath profile and which parts of the breath profile are relatively stable over a period of time.
Objectives:
The primary objective of this pilot study is to assess the intra-individual variability of breath profiles sampled over a period of 98 days.
Eligibility:
DCEG volunteers aged 30-60 years, inclusive.
Design:
Pilot study.
Five DCEG volunteers will be enrolled for this study.
We will assess breath profiles sampled in duplicate at three time periods (days 1, 49 and 98).
We will calculate a coefficients of variation (CV) to determine the proportion and parts of the breath profile which have values less than 10% when collected on the same day,49 days apart, and 98 days apart.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Maryland
-
Bethesda, Maryland, Förenta staterna, 20892
- National Cancer Institute (NCI), 9000 Rockville Pike
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
- INCLUSION CRITERIA:
DCEG volunteers aged 30-60 years, inclusive.
EXCLUSION CRITERIA:
Aged less than 30 years. Aged 61 years or older. Individuals who identify themselves to be in any one of the following categories over the next 4 month period:
- Plan to initial a large change in their daily amount of physical activity
- Plan to make large changes to their diet (reduce caloric intake, become a vegetarian etc)
- May possibly move away from the area for a new job, sabbatical, retirement etc
- Plan to attempt to become pregnant
- Have limited availability for any reason including prolonged vacation or business travel
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Statistics of robustness (CV, ICCs)
Tidsram: 98 days
|
98 days
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Michael B Cook, M.D., National Cancer Institute (NCI)
Publikationer och användbara länkar
Allmänna publikationer
- Cook MB, Dawsey SM, Diaw L, Blaser MJ, Perez-Perez GI, Abnet CC, Taylor PR, Albanes D, Virtamo J, Kamangar F. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1966-75. doi: 10.1158/1055-9965.EPI-10-0270. Epub 2010 Jul 20.
- Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002 Jun 20;99(6):860-8. doi: 10.1002/ijc.10427. Erratum In: Int J Cancer 2002 Oct 20;101(6):599.
- Perera FP. Cancer: the big questions to address in coming years. Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):571-3. doi: 10.1158/1055-9965.EPI-11-0184. No abstract available.
Studieavstämningsdatum
Studera stora datum
Studiestart
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 999911243
- 11-C-N243
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Mänskliga volontärer
-
USDA, Western Human Nutrition Research CenterUniversity of Copenhagen; Bill and Melinda Gates Foundation; International... och andra samarbetspartnersRekryteringHuman Milk Nutrient ReferensvärdenDanmark, Bangladesh, Brasilien, Gambia
-
Instituto Valenciano de Infertilidad, IVI VALENCIAIgenomixAvslutadGenomisk Human Endometrial Expression ProfileSpanien
-
Filip Krag KnopUniversity of CopenhagenAvslutadAtt bedöma effekten av gallsyror på utsöndring av human glukagon-liknande peptid-1Danmark
-
Washington University School of MedicineMerck Sharp & Dohme LLCIndragenHuman T-cell Leukemi Virus Typ 1 Infektion
-
HutchmedAktiv, inte rekryterandeImumun Trombocytopeni (ITP) Human Mass BalanceKina
-
Medigen Vaccine Biologics Corp.Avslutad
-
Medigen Vaccine Biologics Corp.Avslutad
-
Jinling Hospital, ChinaOkändCrohns sjukdom | Metylering | Illumina Human Methylation 850k BeadChipKina
-
University Hospital, Clermont-FerrandOkändHypoalbuminemi | Vuxen intensivpatient | Stewarts tillvägagångssätt för syrabassjukdomar | Human Albumin PerfusionFrankrike
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... och andra samarbetspartnersOkändHuman epidermal tillväxtfaktor 2 negativt bröstkarcinomKina